A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia

Hayat Mushcab,1 Jaffar A Al-Tawfiq,2– 4 Mohammed Ghamdi,5 Amani Babgi,6 Abdulrazack Amir,7 Salwa S Sheikh,8 Adel Darwisheh,9 Abrar Alobaid,9 Arulanantham Zechariah Jebakumar,10 Saeed Qahtani,11 Ahmed Al Sagheir1 1Research Office, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arab...

Full description

Bibliographic Details
Main Authors: Mushcab H, Al-Tawfiq JA, Ghamdi M, Babgi A, Amir A, Sheikh SS, Darwisheh A, Alobaid A, Jebakumar AZ, Qahtani S, Al Sagheir A
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/a-cohort-study-of-seroprevalence-of-antibodies-against-sars-cov-2-infe-peer-reviewed-fulltext-article-IDR
_version_ 1811339192309907456
author Mushcab H
Al-Tawfiq JA
Ghamdi M
Babgi A
Amir A
Sheikh SS
Darwisheh A
Alobaid A
Jebakumar AZ
Qahtani S
Al Sagheir A
author_facet Mushcab H
Al-Tawfiq JA
Ghamdi M
Babgi A
Amir A
Sheikh SS
Darwisheh A
Alobaid A
Jebakumar AZ
Qahtani S
Al Sagheir A
author_sort Mushcab H
collection DOAJ
description Hayat Mushcab,1 Jaffar A Al-Tawfiq,2– 4 Mohammed Ghamdi,5 Amani Babgi,6 Abdulrazack Amir,7 Salwa S Sheikh,8 Adel Darwisheh,9 Abrar Alobaid,9 Arulanantham Zechariah Jebakumar,10 Saeed Qahtani,11 Ahmed Al Sagheir1 1Research Office, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 2Infectious Disease Unit – Specialty Internal Medicine, and Quality and Patient Safety Department, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 3Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; 4Infectious Disease Division, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 5Population Health Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; 6Clinical Practice Education & Research, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 7Office of Academic Affairs, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 8Pathology Department, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 9Laboratory Services Department, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 10Vice Deanship of Postgraduate Studies Research, Prince Sultan Military College of Health Sciences, Dhahran, Eastern Province, Saudi Arabia; 11Wellness Institute, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi ArabiaCorrespondence: Hayat Mushcab, Research Office, Johns Hopkins Aramco Healthcare, Dhahran, 31311, Eastern Province, Saudi Arabia, Tel +966540066447, Email hayat.almushcab@jhah.comBackground: The nature of the healthcare workers’ jobs standing at the frontline against the coronavirus disease 2019 (COVID-19) puts them at a higher risk of unknowingly contracting the disease and potentially contributing to the spread. This study aims to assess the overall positive seroconversion prevalence of SARS-CoV-2.Methods: This is a longitudinal cohort study of healthcare workers at Johns Hopkins Aramco Healthcare (JHAH). JHAH is a tertiary hospital located in Dhahran serving patients in several districts in the Eastern Province of Saudi Arabia. Participants were recruited between June and December 2020. Each participant had a serology blood test and completed the World Health Organization’s risk factor assessment questionnaire.Results: This study included 682 participants working in JHAH, representing 15.7% of our population. Out of the 682 participants, 15.2% had a positive SARS-CoV-2 rt-PCR before taking part in the study. However, only 87 tested positive for SARS-CoV-2 antibodies, a prevalence of 12.7% of all participants. Out of the 87 positives for SARS-CoV-2 antibodies, 17 participants never tested positive for COVID-19 rt-PCR, a prevalence of 2.9%. Moreover, not properly using alcohol-based hand rub or soap and water after the risk of body fluid exposure and wearing personal protective equipment when indicated were found to be statistically significant to having a positive SARS-CoV-2 IgG assay.Conclusion: Positive seroconversion rate was considerably low during the first wave of COVID-19 amongst JHAH’s healthcare workers and similar to other healthcare organizations in Saudi Arabia. Seropositivity correlated significantly with following infection prevention and control recommendations.Clinicaltrials.gov Identifier: NCT04469647.Keywords: COVID-19, coronavirus disease-2019, HCW, healthcare workers, prevalence, SARS-CoV-2
first_indexed 2024-04-13T18:21:42Z
format Article
id doaj.art-88d3d85b1383488798e03500dedf3efb
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-04-13T18:21:42Z
publishDate 2022-08-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-88d3d85b1383488798e03500dedf3efb2022-12-22T02:35:24ZengDove Medical PressInfection and Drug Resistance1178-69732022-08-01Volume 154393440677264A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi ArabiaMushcab HAl-Tawfiq JAGhamdi MBabgi AAmir ASheikh SSDarwisheh AAlobaid AJebakumar AZQahtani SAl Sagheir AHayat Mushcab,1 Jaffar A Al-Tawfiq,2– 4 Mohammed Ghamdi,5 Amani Babgi,6 Abdulrazack Amir,7 Salwa S Sheikh,8 Adel Darwisheh,9 Abrar Alobaid,9 Arulanantham Zechariah Jebakumar,10 Saeed Qahtani,11 Ahmed Al Sagheir1 1Research Office, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 2Infectious Disease Unit – Specialty Internal Medicine, and Quality and Patient Safety Department, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 3Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; 4Infectious Disease Division, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 5Population Health Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; 6Clinical Practice Education & Research, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 7Office of Academic Affairs, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 8Pathology Department, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 9Laboratory Services Department, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi Arabia; 10Vice Deanship of Postgraduate Studies Research, Prince Sultan Military College of Health Sciences, Dhahran, Eastern Province, Saudi Arabia; 11Wellness Institute, Johns Hopkins Aramco Healthcare, Dhahran, Eastern Province, Saudi ArabiaCorrespondence: Hayat Mushcab, Research Office, Johns Hopkins Aramco Healthcare, Dhahran, 31311, Eastern Province, Saudi Arabia, Tel +966540066447, Email hayat.almushcab@jhah.comBackground: The nature of the healthcare workers’ jobs standing at the frontline against the coronavirus disease 2019 (COVID-19) puts them at a higher risk of unknowingly contracting the disease and potentially contributing to the spread. This study aims to assess the overall positive seroconversion prevalence of SARS-CoV-2.Methods: This is a longitudinal cohort study of healthcare workers at Johns Hopkins Aramco Healthcare (JHAH). JHAH is a tertiary hospital located in Dhahran serving patients in several districts in the Eastern Province of Saudi Arabia. Participants were recruited between June and December 2020. Each participant had a serology blood test and completed the World Health Organization’s risk factor assessment questionnaire.Results: This study included 682 participants working in JHAH, representing 15.7% of our population. Out of the 682 participants, 15.2% had a positive SARS-CoV-2 rt-PCR before taking part in the study. However, only 87 tested positive for SARS-CoV-2 antibodies, a prevalence of 12.7% of all participants. Out of the 87 positives for SARS-CoV-2 antibodies, 17 participants never tested positive for COVID-19 rt-PCR, a prevalence of 2.9%. Moreover, not properly using alcohol-based hand rub or soap and water after the risk of body fluid exposure and wearing personal protective equipment when indicated were found to be statistically significant to having a positive SARS-CoV-2 IgG assay.Conclusion: Positive seroconversion rate was considerably low during the first wave of COVID-19 amongst JHAH’s healthcare workers and similar to other healthcare organizations in Saudi Arabia. Seropositivity correlated significantly with following infection prevention and control recommendations.Clinicaltrials.gov Identifier: NCT04469647.Keywords: COVID-19, coronavirus disease-2019, HCW, healthcare workers, prevalence, SARS-CoV-2https://www.dovepress.com/a-cohort-study-of-seroprevalence-of-antibodies-against-sars-cov-2-infe-peer-reviewed-fulltext-article-IDRcovid-19coronavirus disease -2019hcwhealthcare workersprevalencesars-cov-2
spellingShingle Mushcab H
Al-Tawfiq JA
Ghamdi M
Babgi A
Amir A
Sheikh SS
Darwisheh A
Alobaid A
Jebakumar AZ
Qahtani S
Al Sagheir A
A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia
Infection and Drug Resistance
covid-19
coronavirus disease -2019
hcw
healthcare workers
prevalence
sars-cov-2
title A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia
title_full A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia
title_fullStr A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia
title_full_unstemmed A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia
title_short A Cohort Study of Seroprevalence of Antibodies Against SARS-CoV-2 Infection Among Healthcare Workers at a Tertiary Hospital in Saudi Arabia
title_sort cohort study of seroprevalence of antibodies against sars cov 2 infection among healthcare workers at a tertiary hospital in saudi arabia
topic covid-19
coronavirus disease -2019
hcw
healthcare workers
prevalence
sars-cov-2
url https://www.dovepress.com/a-cohort-study-of-seroprevalence-of-antibodies-against-sars-cov-2-infe-peer-reviewed-fulltext-article-IDR
work_keys_str_mv AT mushcabh acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT altawfiqja acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT ghamdim acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT babgia acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT amira acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT sheikhss acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT darwisheha acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT alobaida acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT jebakumaraz acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT qahtanis acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT alsagheira acohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT mushcabh cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT altawfiqja cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT ghamdim cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT babgia cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT amira cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT sheikhss cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT darwisheha cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT alobaida cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT jebakumaraz cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT qahtanis cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia
AT alsagheira cohortstudyofseroprevalenceofantibodiesagainstsarscov2infectionamonghealthcareworkersatatertiaryhospitalinsaudiarabia